MedTrace Logo

Safety, Efficacy, and Tolerance of Pico-Salax for Colon Cleansing Prior to Colonoscopy in an Elderly Population

NCT00906217 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2024-04-03

No results posted yet for this study

Summary

This study aims to further define the appropriate population for Pico-Salax, a purgative used prior to colonoscopy. Patients over the age of 70 years with normal renal function scheduled for colonoscopy will receive Pico-Salax and have pre and post preparation bloodwork and electrocardiograms (ECGs).

Conditions

  • Colon Cleansing

Sponsors & Collaborators

  • Queen's University

    lead OTHER

Principal Investigators

  • Lawrence Hookey, MD · Queen's University

Eligibility

Min Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2010-07-31
Completion
2011-09-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00906217 on ClinicalTrials.gov